Clearside Biomedi (CLSD)

$0.32 -0.03 (-8.61%)
Market Cap 26.06M
Revenue (ttm) 1.66M
Net Income (ttm) -34.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,069.28%
Debt to Equity Ratio 0.00
Volume 1,351,424
Avg Vol 5,568,396
Day's Range N/A - N/A
Shares Out 78.51M
Stochastic %K 52%
Beta 2.11
Analysts Sell
Price Target $4.00

Company Profile

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch...

Industry: Biotechnology
Sector: Healthcare
Phone: 678 270 3631
Fax: 678 270 4033
Address:
900 North Point Parkway, Suite 200, Alpharetta, United States
buyandsold
buyandsold Mar. 15 at 9:02 PM
$CLSD what were terms of HCR settlement
0 · Reply
Qora
Qora Mar. 12 at 3:00 AM
$CLSD uh, HCR and Clearside settled, does that mean no reorg?
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Mar. 11 at 5:44 PM
$CLSD clsd and hcr have settled separate auction for excess royalties
1 · Reply
wishpotion
wishpotion Mar. 10 at 7:20 AM
$CLSD Have not posted anything substantial for a while. Not much to do then sitting and waiting for whatever happens. I have noticed some discussions back and forth here. As I assumed we have now a legal to legal clash with HCR. As long this is not solved nothing more concrete can be done. My resulting strategy is still the same as before, not trading only holding till they found some way to handle the situation. Selling now makes no sense buying now is also something I would not risk if you would ask me. Good luck to all who are still here!
0 · Reply
Stash_Cash
Stash_Cash Mar. 6 at 7:48 PM
$CLSD funding my Schwab brokerage account so I can buy CLSDQ 😁
2 · Reply
Dasmin
Dasmin Mar. 6 at 4:17 PM
$CLSD @rando321456 I know that shares are cheap and the pieces of pie are cheaper to acquire right now, but the shares I bought last year are they still the same piece of pie that I had???? That’s all I care about
1 · Reply
maphere
maphere Mar. 6 at 3:23 PM
$CLSD $RGNX from Regenxbio 10-K We rely on third-party suppliers, including sole-source suppliers, for materials and key components used in our preclinical and clinical studies and for potential commercial use. Clearside supplies the SCS Microinjector under an option and license agreement; however, in November 2025, Clearside filed for Chapter 11 bankruptcy protection and is seeking to sell substantially all of its assets, including the SCS Microinjector, through a court-supervised process, the outcome of which is uncertain. Any disruption in supply, failure of a purchaser to honor our contractual arrangements, or inability to secure continued supply or alternative delivery technology on commercially reasonable terms and in a timely manner could delay or prevent development or commercialization of product candidates that rely on this technology, including our sura-vec programs for Wet AMD and DR, and may adversely affect our business, financial condition, and results of operations.
1 · Reply
buyandsold
buyandsold Mar. 6 at 3:24 AM
$CLSD i have been bidding .44 for 10,000 shares. No bites
0 · Reply
rando321456
rando321456 Mar. 6 at 2:48 AM
$CLSD baby chance here for a reorg
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Mar. 5 at 8:39 PM
$CLSD hearing sched for the 13th
0 · Reply
Latest News on CLSD
No data available.
buyandsold
buyandsold Mar. 15 at 9:02 PM
$CLSD what were terms of HCR settlement
0 · Reply
Qora
Qora Mar. 12 at 3:00 AM
$CLSD uh, HCR and Clearside settled, does that mean no reorg?
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Mar. 11 at 5:44 PM
$CLSD clsd and hcr have settled separate auction for excess royalties
1 · Reply
wishpotion
wishpotion Mar. 10 at 7:20 AM
$CLSD Have not posted anything substantial for a while. Not much to do then sitting and waiting for whatever happens. I have noticed some discussions back and forth here. As I assumed we have now a legal to legal clash with HCR. As long this is not solved nothing more concrete can be done. My resulting strategy is still the same as before, not trading only holding till they found some way to handle the situation. Selling now makes no sense buying now is also something I would not risk if you would ask me. Good luck to all who are still here!
0 · Reply
Stash_Cash
Stash_Cash Mar. 6 at 7:48 PM
$CLSD funding my Schwab brokerage account so I can buy CLSDQ 😁
2 · Reply
Dasmin
Dasmin Mar. 6 at 4:17 PM
$CLSD @rando321456 I know that shares are cheap and the pieces of pie are cheaper to acquire right now, but the shares I bought last year are they still the same piece of pie that I had???? That’s all I care about
1 · Reply
maphere
maphere Mar. 6 at 3:23 PM
$CLSD $RGNX from Regenxbio 10-K We rely on third-party suppliers, including sole-source suppliers, for materials and key components used in our preclinical and clinical studies and for potential commercial use. Clearside supplies the SCS Microinjector under an option and license agreement; however, in November 2025, Clearside filed for Chapter 11 bankruptcy protection and is seeking to sell substantially all of its assets, including the SCS Microinjector, through a court-supervised process, the outcome of which is uncertain. Any disruption in supply, failure of a purchaser to honor our contractual arrangements, or inability to secure continued supply or alternative delivery technology on commercially reasonable terms and in a timely manner could delay or prevent development or commercialization of product candidates that rely on this technology, including our sura-vec programs for Wet AMD and DR, and may adversely affect our business, financial condition, and results of operations.
1 · Reply
buyandsold
buyandsold Mar. 6 at 3:24 AM
$CLSD i have been bidding .44 for 10,000 shares. No bites
0 · Reply
rando321456
rando321456 Mar. 6 at 2:48 AM
$CLSD baby chance here for a reorg
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Mar. 5 at 8:39 PM
$CLSD hearing sched for the 13th
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Mar. 3 at 6:19 PM
$CLSD todays filing reads CLSD in talks with HCR amongst other things hearing on the 5th what do you guys think
1 · Reply
Dasmin
Dasmin Feb. 25 at 7:12 PM
$CLSD I still wanna know what’s gonna happen here
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Feb. 23 at 7:06 PM
$CLSD has anyone seen anything to indicate Change of Control can't be resolved in early march followed shortly thereafter by the auction that will in all likelihood yield quite a bit more than the current ask of .57
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Feb. 23 at 4:01 PM
$CLSD A monday morning survey: Anyone here 1. Buying 2. Selling 3. Neither Since I asked i'll go first: buying
4 · Reply
buyandsold
buyandsold Feb. 22 at 2:48 AM
$CLSD our dockets have produced more paper than the Epstein files, and they have just as many predators.
0 · Reply
JaumeIII
JaumeIII Feb. 19 at 9:33 AM
$CLSD I have no doubt that cls-ax would have performed much better than the $OCUL trial with all comers and every 6 month dosing…with zero chance of endophthalmitis. Maybe some pharma co will see this and pick it up. The risk/ reward is worth it if you are flush!
1 · Reply
Qora
Qora Feb. 18 at 3:16 AM
$CLSD @jbal @rando321456 Any chance of a decent or ok outcome at this point?
1 · Reply
jbal
jbal Feb. 17 at 10:46 PM
$CLSD The ocul call was a bizarre dramatic reading of a script by the ceo and 2 "KOLs" that took a full 45 minutes. They took 3 questions, non-answered them like politicians, and cut it off at 1:05 because of some unknown time constraint, as if they only put one hour on the meter. The presentation was a masterclass of putting lipstick on on a pig. CLS-AX slightly outperformed axpaxli at 24 weeks, in a much harder to treat cohort. CLSD didn't reveal much detail in the ODYSSEY safety profile, but Axpaxli's is a train wreck, as hard the the CEO tries to spin it otherwise. None of this is of any value to CLSD shareholders now as George drove it off a cliff months ago. No new bidders are going to look at the data and palm smack their forehead and realize that the presumption that ocul's insert was a category killer was a fantasy birthed by their CEO.
2 · Reply
rando321456
rando321456 Feb. 17 at 12:04 PM
$OCUL $CLSD Brutal sorry guys, the CLS-AX readout was the canary in the coal mine for axitinib. I was hoping they would show some numbers that wowed.
1 · Reply
rando321456
rando321456 Feb. 16 at 8:57 PM
$CLSD It'll be super interesting if ocul not bidding here is a tell that their results are bad and more broadly that TKIs as a class of drug do not interface with wet AMD as well as everyone hoped. Just from first principles one would think they would bid a million or two to prevent the only other way to treat Wet AMD with their API from being developed any further. That is if they truly believed their results would drive a multi-billion dollar drug. Though given what's been observed from Clearside this will be a billion dollar class of drugs and the people in the company are so overwhelmingly incompetent that they could not do anything with that.
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Feb. 16 at 5:34 PM
$CLSD when the auction resumes whats the chances we have more bidders at the table abbv rgnx? etc
0 · Reply
Clifden
Clifden Feb. 13 at 2:08 PM
$CLSD Jimmy Dunne from Piper Sandler was on CNBC today with Joe Kiernan . Too bad they didn’t have an investor call in session. Would of asked him WTF happened to this POS investment even they couldn’t offload. I’m still invested with all my shares and took a good beating. Maybe I can take my wife, kids, grandkids out for a nice steak/lobster dinner when this settles. Other than that its Mickey D’s 😂. Management F’d this from the get go as they have done with numerous other small biotechs. Milk the investor and ride off into the sunset a millionaire. It’s all on me, Bio investings a bitch !! GLTA
0 · Reply